Blog
About

6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Atrial Electromechanical Delay Is Impaired in Patients with Psoriasis

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          In this study, we aimed to investigate atrial electromechanical delay (EMD) in patients with psoriasis.

          Subjects and Methods

          A total of 43 patients with psoriasis (26 mild-moderate, 17 severe) and 17 healthy control subjects were enrolled. Patients with psoriasis were divided into two groups: the mild-moderate group and the severe group according to their psoriasis area severity index (PASI) scores. Atrial EMD was measured from the lateral mitral annulus and called ‘PA lateral’, from the septal mitral annulus, called ‘PA septal’, and from the right ventricle tricuspid annulus, called ‘PA tricuspid’. Atrial EMD was defined as the time interval from the onset of atrial electrical activity (P wave on surface ECG) to the beginning of mechanical atrial contraction (late diastolic A wave). All three groups were compared with each other, and correlation analysis was performed to investigate the relationship between the PASI score and interatrial EMD.

          Results

          PA lateral was significantly higher in both the mild-moderate psoriasis group and the severe psoriasis group compared to controls (69 ± 12 and 78 ± 13 vs. 60 ± 6 ms; p = 0.001). Also, PA septal (63 ± 11 vs. 53 ± 6 ms; p = 0.005, post hoc analysis) and PA tricuspid (49 ± 7 vs. 41 ± 5 ms; p = 0.009, post hoc analysis) were significantly higher in the severe psoriasis group than in the control group. Correlation analysis revealed that the PASI score was well correlated with PA lateral (r = 0.520, p < 0.001), PA septum (r = 0.460, p = 0.002), interatrial EMD (r = 0.371, p = 0.014) and intra-atrial EMD (r = 0.393, p = 0.009).

          Conclusion

          Atrial EMD was prolonged in patients with psoriasis. The measurement of atrial EMD might be used to determine the risk of development of AF in patients with psoriasis.

          Related collections

          Most cited references 25

          • Record: found
          • Abstract: not found
          • Article: not found

          Psoriasis.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).

               ,  G Gregoratos,   (2003)
                Bookmark

                Author and article information

                Affiliations
                aDepartment of Cardiology, Kayseri Education and Research Hospital, Kayseri, Turkey
                bDepartment of Dermatology, Kayseri Education and Research Hospital, Kayseri, Turkey
                cDepartment of Department of Cardiology, Erciyes University, School of Medicine, Kayseri, Turkey
                Author notes
                *Bahadir Sarli, MD, Department of Cardiology, Kayseri Education and Research Hospital, TR–38010 Kayseri (Turkey), E-Mail drsarli@ 123456yahoo.com
                Journal
                Med Princ Pract
                Med Princ Pract
                MPP
                Medical Principles and Practice
                S. Karger AG (Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch )
                1011-7571
                1423-0151
                January 2015
                19 August 2014
                19 August 2014
                : 24
                : 1
                : 30-35
                mpp-0024-0030
                10.1159/000365760
                5588181
                25138738
                Copyright © 2014 by S. Karger AG, Basel

                This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.

                Counts
                Figures: 1, Tables: 2, References: 25, Pages: 6
                Categories
                Original Paper

                Comments

                Comment on this article